FIELD: pharmacology.
SUBSTANCE: in formula , R1 and R2 are independently selected from the group consisting of C12-C18 alkyl, C12-C18 alkenyl and oleyl group; R3 and R4 are independently selected from the group consisting of C1-C6 alkyl and C2-C6 alkanol; X is selected from the group consisting of -CH2- and -S-, or absent; Y is selected from -(CH2)n and -S(CH2)n , where n is 1 to 4; a=1-4; b=1-4; c=1-4 and Z is a counter ion. The invention also relates to a star-cell-specific drug carrier comprising a star-cell-specific amount of a retinoid molecule and a cationic lipid consisting of a compound of formula I.
EFFECT: improved delivery of therapeutic drugs and increased activity thereof.
31 cl, 16 dwg, 14 tbl, 43 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS FOR TARGETED DRUG DELIVERY AND ENHANCING siRNA ACTIVITY | 2012 |
|
RU2769872C2 |
LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS | 2013 |
|
RU2658007C2 |
METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | 2012 |
|
RU2647476C2 |
DISPOSABLE SYSTEM FOR STERILE OBTAINING OF LIPIDS AND NUCLEIC ACIDS PARTICLES | 2012 |
|
RU2642640C2 |
FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | 2018 |
|
RU2808990C2 |
MEANS FOR INTESTINAL FIBROSIS TREATMENT | 2012 |
|
RU2637372C2 |
LIPOSOMS WITH RETYNOID TO STRENGTHEN hsp47 EXPRESSION MODULATION | 2012 |
|
RU2628694C2 |
COMPOSITION CONTAINING DISULPHIDE POLYCATIONIC AMPHIPHILE WITH NEUTRAL PHOSPHOLIPIDE AND METHOD FOR PRODUCING THEREOF | 2016 |
|
RU2610271C1 |
COMPOSITION FOR RECOVERY OF NORMAL TISSUE FROM FIBROUS TISSUE | 2011 |
|
RU2650796C2 |
IONONE-BASED VANILLOID VRI RECEPTOR ANTAGONISTS | 2007 |
|
RU2447064C2 |
Authors
Dates
2017-10-11—Published
2012-06-08—Filed